Randomized trial · people
Kisspeptin-10 raised osteocalcin by up to 20.3% in healthy men
Checked against the paper Randomized trialPublished by PepVault
The takeaway
Kisspeptin briefly raised a bone-building blood marker in healthy men, an early human signal on bone that has not been tested over longer use or in people with bone loss.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 26
- Published
- 2022
- Journal
- J Clin Endocrinol Metab
What they tested
Does kisspeptin change bone metabolism in human bone cells in the lab and in healthy men?
How the study was done
A randomized, double-blind, placebo-controlled crossover trial in 26 healthy young men (each got kisspeptin and placebo), with blood drawn every 30 minutes for 90 minutes. Alongside it, a lab study tested kisspeptin on bone cells from 12 male blood donors and 8 hip replacement patients.

What they found
In human bone cells in the lab, kisspeptin raised alkaline phosphatase in bone marrow stem cells by 41.1% and cut the bone-breakdown activity of osteoclasts by up to 53.4%, with larger effects at higher doses. In the men, kisspeptin raised total osteocalcin by up to 20.3% and carboxylated osteocalcin by up to 24.3%, both markers of bone building. Markers of bone breakdown did not change, and the effect did not depend on sex hormone levels.
What it doesn’t show
This was a single 90-minute test in young, healthy men, so it shows short-term shifts in blood markers, not changes in bone density or fractures. The lab results come from cells, not from people.
The paper
Comninos et al. Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men. J Clin Endocrinol Metab. 2022.
The compound
More studies on Kisspeptin-10
- Kisspeptin-10: daily 8 h infusions kept LH raised for 12 days in menRandomized trial · people · 2026
- Every study on Kisspeptin-10
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.